PND1 ASSESSING THE NET CLINICAL BENEFIT AND ABSOLUTE RISK REDUCTION OF DISEASE MODIFYING DRUGS IN RELAPSING REMITTING MULTIPLE SCLEROSIS

✍ Scribed by A AL-Sabbagh; R Bennett; R Glanzman

• Book ID: 118608363
• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 69 KB
• Volume: 10
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)68800-6